Blue Therapeutics was founded in 2014 by Ajay Yekkirala, David Roberson, Michio Painter and academic founder Phil Portoghese. Blue was born out of the desire to transform decades of academic knowledge into therapeutic solutions that can have positive and lasting impacts for patients in the clinic. Working in New England where the opioid epidemic has struck particularly hard, this meant asking ourselves why better therapeutic options for pain don't exist. Why do patients have to choose between pain relief and the potential for addiction? Our core belief is that no one should have to make this choice and the result is the revolutionary technology being developed by Blue.

Our company began at the Harvard Innovation Launch Lab, a start-up incubator and co-working space for select Harvard alumni ventures based on the Harvard Business School campus. In March 2018 we moved to our current offices at 625 Massachusetts Avenue in Cambridge, MA. Our relocation to the Cambridge biotech sector provides us with improved access to veteran biotech leaders with business expertise across all areas of drug discovery & development.

Harvard Innovation Launch Lab